A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

Humans are masters of seeing faces in any old thing—a handbag, TV static, toasted white bread. Scientists want to know why. A few years ago, as the category 5 Hurricane Milton bore down on the Florida ...

LONDON, March 18 (Reuters) - Britain plans to consider requiring labels on AI-generated content to protect consumers from disinformation and deepfakes, the government said on Wednesday, as it outlined ...

The shooting happened about 26 hours after the United States and Israel attacked Iran. Officials identified the three who died in the shooting. By Thomas Fuller Investigators are looking into whether ...

A research team led by Prof. Xiao Kai from the Yantai Institute of Coastal Zone Research of the Chinese Academy of Sciences has systematically elucidated the transformation and transport processes of ...

From the Department of Bizarre Anomalies: Microsoft has suppressed an unexplained anomaly on its network that was routing traffic destined to example.com—a domain reserved for testing purposes—to a ...

In this paper, we explore multiple intellectual traditions that inspire and inform the subfield of stratification economics—a subfield of economics that emerged out of the desire to better explain ...

A risk-based screening strategy shows high efficacy and significant reductions in cost in the detection of upper gastrointestinal cancers compared with conventional universal screening, results from a ...

Offer Reverent Sacrifice and Heed the Primordial Deity's Will - Shrine Dwelling Riddle Solution 1 Offer Reverent Sacrifice and Heed the Primordial Deity's Will - Shrine Dwelling Riddle Solution 2 ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. The Department of Veterans Affairs (VA) has announced a new partnership with the Centers for Medicare and Medicaid ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They found the drug slowed cognitive decline by 46% in a group of patients with ...